Tectonic Therapeutic Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Tectonic Therapeutic Inc 's ROA in the second quarter of 2026?
Tectonic Therapeutic Inc recorded a cumulative net loss of $-86 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -33.59%.

However, within the Healthcare sector 445 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3652, from total ROA ranking in the first quarter of 2026 at 4189.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	-19.73 %	-21.68 %	70.72 %	64.18 %	52.29 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-86	-83	-74	-67	-66
Return On Assets (TTM)	-33.59 %	-30.92 %	-25.83 %	-25.88 %	-28.32 %
TECX's Total Ranking	# 3652	# 4189	# 3746	# 3824	# 3888
Total Assets (TTM) in million	237	247	261	277	295
Seq. Total Assets Change	-3.87 %	-5.54 %	-5.76 %	-6.2 %	-6.2 %
Seq. Net Income Change	-	-	-	-	-

TECX's 5 Years Annual ROA >> Back to TECX Management Effectiveness >> Compare TECX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 49
Sector	# 446
Overall	# 3665

Return On Assets Statistics
High	Average	Low
-25.83 %	-48.97 %	-78.24 %
(Dec 31 2025)		(Mar 31 2023)

Financial Statements
Tectonic Therapeutic Inc 's Assets	$ 237 million	TECX's Balance sheet
Tectonic Therapeutic Inc 's Income	$ -22 million	Quarterly TECX's Income Statement
TECX's Income by Division		See TECX's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	70.72 %	51.25 %	-2.75 %	-49 %	-24.85 %
Total Assets in million	261	153	101	104	204
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-74	-58	25	-106	-119
Annual Return On Assets	-28.41 %	-37.92 %	24.42 %	-101.87 %	-58.44 %

TECX's 5 Years Annual ROA >> Back to TECX Management Effectiveness >> Compare TECX ROA to its Competitors

More Return On Assets Ratios
TECX's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TECX's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TECX's Competitors
Subscribers only: Roa for Tectonic Therapeutic Inc 's Suppliers
Subscribers only: Return On Assets for TECX's Customers

You may also want to know
TECX's Roi	TECX's Inventory Turnover Ratio	TECX's Growth Rates	TECX's Dividend Comparisons
	TECX's Profitability Ratios	TECX's Asset Turnover Ratio	TECX's Dividend Growth
TECX's Roe	TECX's Valuation Ratios	TECX's Financial Strength Ratios	TECX's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-26T07:34:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.